Conceptio › Archive › NCBI PubMed Central
NCBI PubMed Centralopen access

Adjuvant disitamab vedotin plus PD-1 blockade and gemcitabine/cisplatin in high-risk upper tract urothelial carcinoma: a two-stage real-world comparative study.

Wang C et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗Direct PDF ↓
information security management
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 330935
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.